STOCK TITAN

Ani Pharmaceutic (ANIP) Free Cash Flow by Year

ANIP

Ani Pharmaceutic generated $171.4M in free cash flow in fiscal year 2025. This represents an increase of 258.7% from the prior fiscal year. Over the trailing 12 months, Q3 FY2025 through Q2 FY2026, the same line adds up to $173.0M in free cash flow. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters Ani Pharmaceutic has filed alongside them.

FY2025 annual
Free Cash Flow $171.4M
YoY +258.7%
5Y CAGR +79.8%
10Y CAGR +27.5%
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

ANIP Free Cash Flow by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricTTMFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-KFY1510-KFY1410-KFY1310-KFY1210-KFY1110-K
Free Cash Flow$173.0M$171.4M+258.7%$47.8M-56.6%$110.1M+374.7%-$40.1M-5339.1%$765K-91.6%$9.1M-76.6%$39.0M-36.4%$61.3M+111.1%$29.1M+26.8%$22.9M+51.9%$15.1M-27.9%$20.9M+468.5%-$5.7M-1222.8%-$429K+99.1%-$48.6M

TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.

ANIP Free Cash Flow by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-Q
Free Cash Flow$53.6M-25.3%$52.3M+60.8%$29.1M+116.3%$38.0M+395.3%$71.8M+453.8%$32.5M+137.6%$13.5M-68.3%$7.7M-74.8%$13.0M-28.5%$13.7M-28.2%$42.5M+663.3%$30.4M+2534.6%

What free cash flow means

Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper.

More Ani Pharmaceutic financials

Frequently Asked Questions

What was Ani Pharmaceutic's free cash flow in fiscal year 2025?

Ani Pharmaceutic generated $171.4M in free cash flow in fiscal year 2025.

How fast is Ani Pharmaceutic's free cash flow growing?

Ani Pharmaceutic (ANIP) free cash flow rose by 258.7% year over year, from $47.8M to $171.4M in fiscal year 2025.

What is Ani Pharmaceutic's free cash flow over the last twelve months?

Ani Pharmaceutic (ANIP) reported $173.0M in free cash flow over the trailing 12 months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.

Across the 15 fiscal years this page covers, Ani Pharmaceutic (ANIP) free cash flow went from -$48.6M in fiscal year 2011 to $171.4M in fiscal year 2025.

Ani Pharmaceutic (ANIP) reported $53.6M in free cash flow in Q2 2026. This represents a decrease of 25.3% from the same quarter a year earlier.

Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper. This page lists what Ani Pharmaceutic (ANIP) reported on that line in every period on record.